It's the simpler, more affordable counterpart to the IHADA Clear Balm — squalane-leading rather than petrolatum-leading, single quasi-drug active rather than three, slightly tinted opaque appearance rather than translucent clear. The simpler formulation makes this the more budget-friendly daily-driver IHADA occlusive option for users who don't need the brightening active or the air-light texture.
The simpler, more affordable counterpart to the IHADA Clear Balm — squalane-leading rather than petrolatum-leading, single stearyl glycyrrhetinate soothing active rather than three, slightly tinted opaque finish rather than translucent. Same fragrance-free, alcohol-free pharmacy-grade formulation discipline. Strong daily-driver value at pharmacy-tier pricing for users who don't need the brightening active.
The case for it
What would change this: A researched evidence row for the lead active would replace this with a verdict.
Same rule for everyone. “Good choice” is the verdict on 1,938 of 45,024 concern verdicts across the catalog; rule F2 decided 1,938 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R3 decided 567 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A declared concentration would move this to a firmer reading of the dose.
Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R3 decided 567 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
Also listed for Winter Skin — the actives here (Squalane, Petrolatum, Emollient Esters, Silica) are in our research queue for that concern; there is no verdict until their evidence rows are written. That is a gap in our table, not a mark against the product.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
When a brand offers two versions of a similar product at different price points, the simpler version is usually what most users actually buy. The IHADA Medicated Balm is the line's daily-driver occlusive — focused on barrier support and soothing without the additional brightening active that justifies the Clear Balm's premium. Same fragrance-free, alcohol-free, pharmacy-grade formulation discipline as the rest of the IHADA range, in a squalane-leading rather than petrolatum-leading sequence that gives the balm a slightly more pleasant application feel than typical heavy petrolatum products.
The formulation logic is built around simplicity. Squalane sits first as the texture-improving primary emollient — its skin-mimetic structure, the saturated version of the squalene your own sebum makes, provides emolliency with excellent cosmetic elegance and no comedogenic baggage. Petrolatum sits second as the substantial occlusive backbone — pharmaceutical-grade purity at meaningful concentration that delivers the roughly 90% reduction in transepidermal water loss that makes petrolatum the reference standard in dermatology. The squalane-then-petrolatum sequence creates a smoother application feel than pure petrolatum products while preserving the underlying occlusive mechanism. There's a lingering suspicion that a squalane-first balm must be too light to seal anything, and the INCI answers it directly: the squalane changes how the balm feels, not what it does. The petrolatum immediately behind it is doing the actual sealing, at a concentration that no amount of pleasant texture could disguise.
The supporting cast continues the simplicity-with-quality philosophy. Pentaerythrityl tetraethylhexanoate provides synthetic ester surface conditioning. Hydrogenated poly(C6-12 olefin) and hydrogenated polyisobutene add skin-mimetic hydrocarbon emollient character — structurally close enough to natural sebum components that reactive skin rarely objects to them. Sorbitan sesquiisostearate functions as an emulsifier supporting the formula's structural stability. Silica and titanium oxide give the balm its slightly opaque tinted appearance versus the Clear Balm's translucent finish, plus a soft-focus blur and a modest UV-protective character from the titanium. Cyclomethicone and dimethicone provide the light silicone slip that stops the whole thing from dragging across tender skin. Twelve ingredients, total. Nothing is in there twice, and nothing is in there for the label.
The single quasi-drug active is stearyl glycyrrhetinate — the licorice-derived anti-inflammatory in a stearyl ester form that has better skin penetration than the dipotassium glycyrrhizate used in other IHADA products. The Japanese regulatory framework approved this active for sensitive-skin soothing claims, giving the balm its 'Medicated' positioning, which in the Japanese quasi-drug system is a specific regulatory category rather than a marketing adjective. Single-active focus keeps the formulation cost down compared to the Clear Balm's three-active stack.
In practical use the balm performs reliably. Take a pea-sized amount on clean fingertips, warm briefly until the balm softens, then apply to targeted areas (lips, around the eyes, dry patches, rough nose contour) or as a final occlusive top layer over a moisturizer for full-face application. The melt-on-contact texture spreads thinly without dragging; absorption takes 60-90 seconds and leaves a barrier-supportive film. The slightly opaque tinted appearance is barely visible on skin after absorption — users who prefer fully translucent finishes should opt for the Clear Balm. It sits comfortably under sunscreen in the morning and as the last thing on the face at night. The comfort is immediate; the fewer-flare-ups payoff builds over two to four weeks, which is roughly how long a chronically reactive complexion takes to stop bracing for the next insult.
On fragrance, the balm holds the same line the whole IHADA range does: nothing perfumed, nothing aromatic, nothing hiding behind a botanical name. It is also alcohol-free, paraben-free, sulfate-free, and free of the usual contact sensitizers, and the absence of plant oils and fatty acids means it clears the fungal-acne bar that most balms trip over. There is real silicone content, and while a small number of people avoid silicones on principle, sensitive complexions almost never react to them.
Value is genuinely strong for the formulation tier. At about $18 for 20g at Japanese pharmacy pricing, the per-gram cost is meaningfully more affordable than the Clear Balm and competitive with mainstream Japanese pharmacy occlusive products. The 20g jar lasts about 2-3 months at targeted daily use, putting monthly cost at about $7 — though anyone using it full-face nightly through a hard winter will empty it far faster, which is the most common complaint from the couple of thousand people who've reviewed it. International markup at non-Japanese retailers can push this to $24-$32, which weakens but doesn't kill the value proposition. Against a plain petrolatum ointment from the drugstore — dramatically cheaper per gram, and genuinely effective at the sealing job — the IHADA premium buys you the pharmaceutical-grade formulation thinking, the far more pleasant texture, and the soothing active that plain petrolatum simply doesn't have.
This suits chronic sensitive, dry, or compromised-barrier complexions that need an occlusive final step and nothing else — eczema-prone skin, post-procedure skin, faces that have simply run out of tolerance for winter. It suits anyone who wants pure barrier-and-soothing function without paying for the Clear Balm's brightening claim, and it is the one IHADA balm that stays available to you during pregnancy and breastfeeding, since it carries no tranexamic acid.
It makes far less sense if brightening is what you're after, in which case the Clear Balm is the product you actually want. Anyone who buys strictly cruelty-free will have to pass, given where Shiseido distributes. Oily skin rarely needs an occlusive seal in the first place. And a budget shopper who only needs the barrier function can get most of the way there with a plain petrolatum ointment for a fraction of the price — without the soothing active, and without any of the elegance, but the seal itself is the same physics.
The broader take: this is what Shiseido Medical's pharmacy-grade thinking produces when applied to the simplest sensitive-skin occlusive use case — squalane-leading for texture, petrolatum-supported for barrier, stearyl glycyrrhetinate for soothing, nothing extra. For users who match the target profile, the IHADA Balm earns its place in the line as the affordable daily-driver occlusive. Most IHADA users would be better served by this standard Balm than by the Clear Balm unless brightening is a specific priority — Shiseido Medical knows this and prices accordingly.
The hero actives that drive this product's performance.
| Ingredient | Function | Evidence |
|---|---|---|
| Squalane (Lead Lipid) | Sits first in the INCI as the formula's primary skin-mimetic emollient — squalane is the saturated stable version of natural sebum squalene, providing emolliency and modest TEWL prevention without comedogenicity. Its position as the lead ingredient is what distinguishes this balm from the petrolatum-leading Clear Balm sibling. | Established mechanism for Dryness · established mechanism |
| Pharmaceutical-Grade Petrolatum | Sits second in the INCI providing the substantial occlusive component — pharmaceutical-grade purity at meaningful concentration delivers the 90% TEWL reduction that characterizes petrolatum's dermatology-gold-standard performance. The squalane-then-petrolatum sequence creates a smoother application feel than pure petrolatum balms. | Regulator-approved for Dryness · established mechanism |
| Stearyl Glycyrrhetinate (Quasi-Drug Active) | A licorice-derived anti-inflammatory and the formula's single quasi-drug active. More potent than the dipotassium glycyrrhizate used in other IHADA products (stearyl form has better skin penetration), providing the medicated soothing claim that makes this a quasi-drug rather than a basic cosmetic balm. | Limited for Eczema |
| Pentaerythrityl Tetraethylhexanoate + Hydrogenated Polyolefins | The synthetic ester emollient and hydrogenated hydrocarbon supporting system provide non-comedogenic surface conditioning that softens the balm's heavy lipid feel. The hydrogenated polyolefins specifically are structurally similar to natural sebum components and well-tolerated by sensitive skin. | Not yet assessed |
| Silica + Titanium Oxide | Silica provides a soft-focus blurring effect on skin surface; titanium dioxide provides modest UV-protective character and adds the formula's slight opacity. Together they give the standard Balm its slightly tinted appearance (versus the Clear Balm's translucent finish). | Not yet assessed |
Ingredient standings describe the active at treatment-level doses and vehicles; this product's own condition grades weigh its actual formula.
Squalane, Petrolatum, Pentaerythrityl Tetraethylhexanoate, Hydrogenated Poly(C6-12 Olefin), Hydrogenated Polyisobutene, Sorbitan Sesquiisostearate, Silica, Dimethicone, Cyclomethicone, Dextrin, Stearyl Glycyrrhetinate, Titanium Oxide
occlusive
AM & PM
Apply as the final routine step over moisturizer. Use a small pea-sized amount and warm between fingertips before applying — the squalane-leading formula melts smoothly on contact. Can be used as a targeted spot treatment on rough patches, lips, around the eyes, or as a complete final occlusive seal for very dry skin.
Immediate barrier-occlusive protection and cushioned comfort on first use; cumulative barrier-improvement and reduced reactivity over 2-4 weeks of consistent use.
The defining chemistry is the squalane-then-petrolatum lipid sequence. Squalane (saturated, stabilized version of natural sebum squalene) provides skin-mimetic emolliency with excellent cosmetic elegance — it integrates into the skin's surface lipid layer to provide softening without the heavy feel of triglyceride oils. Petrolatum at meaningful concentration immediately after delivers the substantial occlusive mechanism, reducing transepidermal water loss by approximately 90% at deposition coverage. The combined approach delivers complete barrier support — emollient softening from squalane, occlusive sealing from petrolatum — in a single product.
Stearyl glycyrrhetinate is the stearyl ester form of glycyrrhetinic acid (the active metabolite of licorice's glycyrrhizin). The stearyl ester form has better lipophilicity and skin penetration than the standard dipotassium glycyrrhizate form, which means it delivers anti-inflammatory activity more effectively in occlusive lipid formulations. The published research on stearyl glycyrrhetinate supports topical anti-inflammatory effects at cosmetic concentrations through inhibition of lipoxygenase and cyclooxygenase pathways.
The hydrogenated polyolefin and hydrogenated polyisobutene are synthetic hydrocarbon emollients structurally similar to natural sebum components. Their stability and skin-mimetic profile make them well-tolerated by sensitive skin and useful for delivering emollient softening without comedogenic risk.
The pentaerythrityl tetraethylhexanoate is a synthetic ester emollient with excellent cosmetic elegance — provides surface conditioning without the heaviness of triglyceride oils.
The silica provides soft-focus surface blurring through optical light scattering. Titanium oxide adds modest UV-protective character (though not at sunscreen-grade concentration) and contributes to the formula's slight opacity that distinguishes the standard Balm from the Clear Balm sibling.
The cyclomethicone and dimethicone provide silicone supporting feel — volatile silicone for the immediate spreading texture, dimethicone for the smoothing surface character. Both are well-tolerated by sensitive skin in cosmetic concentrations.
The dextrin functions as a viscosity modifier and helps stabilize the balm structure.
The IHADA Medicated Balm is among the sensitive-skin barrier balms most frequently suggested by Japanese dermatologists for chronic atopic dermatitis, eczema management, post-procedure recovery, and chronic compromised-barrier presentations where the IHADA Emulsion alone doesn't provide sufficient occlusive support. The squalane-and-petrolatum lipid system delivers reliable barrier support; the stearyl glycyrrhetinate active delivers documented anti-inflammatory mechanism through better-penetrating licorice derivative. Clinically the appealing characteristics are the simple ingredient list, the pharmaceutical-grade petrolatum, the genuine fragrance-free formulation, and the absence of common contact sensitizers. The flags are minimal — this is among the more conservative occlusive balms available in the pharmacy tier. For patients with diagnosed chronic sensitive-skin presentations who need an occlusive step that pairs with the IHADA Lotion + Emulsion routine, this is the standard recommendation in Japanese clinical practice. The Clear Balm is reserved for patients who specifically need the additional tranexamic acid brightening active.
Take a pea-sized amount on clean fingertips. Warm between fingers until the balm softens. Apply to targeted areas — around the eyes, lips, dry patches, rough nose contour — or as a final occlusive top layer over the IHADA Emulsion for full-face application. Allow 60-90 seconds to absorb before applying sunscreen (AM) or any other final layer. For AM use, sparing targeted application works under sunscreen; for PM use, more generous application provides sustained overnight barrier support. Safe for use morning and evening.
At approximately $18 for 20g at Japanese pharmacy pricing, this is competitively priced within the Japanese pharmacy sensitive-skin balm segment and well below Western sensitive-skin specialist balm products. The per-gram cost is significantly more affordable than the IHADA Clear Balm sibling ($22 for 18g — about 50% more per gram). The 20g jar lasts about 2-3 months of typical use, putting monthly cost at about $7. Compared to mass-market petrolatum products (Aquaphor at about $0.05 per gram, Vaseline at about $0.03 per gram), this is dramatically more expensive — but those products don't include the quasi-drug active. The IHADA premium represents the cost of the active inclusion and pharmaceutical-grade formulation thinking. For users who specifically value the active and the pharmacy-grade discipline, the premium is reasonable; for users who just want occlusive barrier support, Aquaphor or pure petrolatum delivers comparable function at dramatically lower cost.
Chronic sensitive, dry, or compromised-barrier complexions completing the IHADA routine with the occlusive step. Anyone seeking pure barrier-and-soothing function without the additional brightening claim of the Clear Balm. Budget-conscious IHADA users. Pregnant or breastfeeding users (the standard Balm avoids the tranexamic acid that's in the Clear Balm). Routine builders looking for a fragrance-free pharmacy-grade balm that pairs cleanly with quasi-drug active products.
Users who specifically want the brightening active (the Clear Balm is the right pick). Cruelty-free purchasers ruled out by Shiseido's mainland China distribution. Silicone-avoiders on principle. Budget shoppers for whom Aquaphor or pure petrolatum delivers comparable barrier support for a quarter of the cost (though without the soothing active).
Ready to try IHADA Medicated Balm?
Buy at Amazon ♥Soft balm with slightly opaque appearance; melts on contact with skin warmth and spreads smoothly without dragging.
Genuinely fragrance-free — only the faint inherent ingredient note typical of a clean balm formulation.
Small plastic jar with screw cap; the jar format allows full extraction.
First application is sensorially gentle and immediately protective — the squalane-leading formula melts on contact and forms a thin barrier-supportive film. No grease, no shine, no heavy feel. Within 2-3 weeks of regular use, chronically reactive complexions typically report better mid-day comfort and fewer post-cleanse flare episodes.
About 2-3 months at targeted-area daily use or every-other-day full-face use from the 20g jar.
All Year
IHADA launched in 2014 as Shiseido Medical's sensitive-skin brand. The standard Medicated Balm was developed as the line's flagship occlusive option — focused on the squalane-and-petrolatum lipid system with stearyl glycyrrhetinate as the single soothing active. The simpler ingredient list and lower price than the Clear Balm sibling makes this the daily-driver IHADA balm for most users.
IHADA is Shiseido Medical's dedicated sensitive-skin pharmacy brand, launched in 2014. The standard Medicated Balm is the line's simplest occlusive-barrier option — focused on the stearyl glycyrrhetinate active and a clean lipid system without the additional brightening claim of the Clear Balm sibling product.
The simpler IHADA Balm is functionally inferior to the multi-active Clear Balm.
For users without specific hyperpigmentation concerns, the simpler Balm delivers the same barrier-support and soothing benefit at lower price. The Clear Balm's additional tranexamic acid only matters if you specifically want the brightening claim — for pure barrier-and-soothing function, the standard Balm is the better value match.
Squalane-leading balms are too light to deliver real barrier support.
Not in this formulation. The squalane sits first as the texture-improving emollient, but petrolatum sits at meaningful concentration immediately after — delivering the 90% TEWL reduction that defines petrolatum-grade barrier support. The squalane just makes the balm feel more pleasant during application without compromising the underlying occlusive mechanism.
Get the standard Balm if you want pure barrier-support and soothing without the brightening active — same regulatory-grade allantoin and licorice mechanism is in the lotion and emulsion. Get the Clear Balm if you specifically want tranexamic acid brightening alongside the barrier support, or if you prefer the air-light translucent texture over the slightly opaque standard Balm finish.
Yes — many users specifically use it on the under-eye area, lip area, and around the nose for chronic dryness. The fragrance-free, ophthalmologist-tolerant formulation makes it appropriate for delicate skin areas. Use sparing amounts and warm between fingertips before applying.
Yes, at sparing amounts on target areas. Apply small dabs to dry patches or rough areas, allow 60-90 seconds to absorb, then apply foundation. Don't use as a full-face moisturizer under makeup — the IHADA Emulsion is the right product for that role.
Yes. The squalane, petrolatum, and stearyl glycyrrhetinate all have established pregnancy-safety records in topical use. No retinoids, no salicylic acid, no tranexamic acid (the Clear Balm has tranexamic acid which has more pregnancy considerations) — this is among the safer balms for use during pregnancy and breastfeeding.
All three are well-formulated occlusive barrier products. Aquaphor and Vaseline are both petrolatum-leading; the IHADA Balm is squalane-leading with petrolatum support. The IHADA also adds the stearyl glycyrrhetinate soothing active that Aquaphor and Vaseline don't include. Aquaphor and Vaseline are dramatically cheaper per gram; the IHADA premium reflects the active inclusion and pharmacy-tier formulation rigor.
Generally no, if applied correctly. Use sparing amounts and warm between fingertips. The squalane-leading texture absorbs into a thinner film than petrolatum-only balms. Allow 60-90 seconds before applying sunscreen, and use a small amount only on target dry areas rather than full-face for AM routines under SPF.
No. Shiseido Medical distributes through mainland China retail channels where animal testing is required by local regulation.
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
Squalane-leading formula feels lighter than the typical heavy petrolatum balm
Genuinely fragrance-free
Stearyl glycyrrhetinate active soothes reactive skin
Pharmaceutical-grade petrolatum delivers real TEWL reduction
Strong value at pharmacy-tier pricing
20g goes quickly with regular use
Slightly tinted opaque appearance (use Clear Balm if translucency matters)
Limited international availability
Verified answers from our questions library — the nuance a product page cannot carry.
